Allergan Must Face Generic Drug Price-Fixing Claims
A New Jersey federal judge Thursday nixed Allergan's bid to toss a generic drug price-fixing lawsuit on the grounds that funds affiliated with TIAA-CREF were too late in filing their claims...To view the full article, register now.
Already a subscriber? Click here to view full article